Table 3.
Summary of the distribution of each indicator. (The numerator represents the number of various time attributes in the indicator; the denominator represents the total amount in the indicator.)
| Risk factors | Indicators | Time attributes | Amount of Training | Amount of testing |
|---|---|---|---|---|
| CAD | Test | Before DCT | 266/311 (86%) | 49/53 (92%) |
| During DCT | 45/311 (14%) | 4/53 (8%) | ||
| After DCT | 0/311 (0%) | 0/53 (0%) | ||
| Mention | Before DCT | 1276/3773 (34%) | 166/504 (33%) | |
| During DCT | 1255/3773 (33%) | 171/504 (34%) | ||
| After DCT | 1242/3773 (33%) | 167/504 (33%) | ||
| Event | Before DCT | 1143/1233 (93%) | 126/135 (93%) | |
| During DCT | 84/1233 (7%) | 8/135 (6%) | ||
| After DCT | 6/1233 (0%) | 1/135 (1%) | ||
| Symptom | Before DCT | 192/281 (68%) | 39/67 (58%) | |
| During DCT | 79/281 (28%) | 25/67 (37%) | ||
| After DCT | 10/281 (4%) | 3/67 (4%) | ||
| Hypertension | Mention | Before DCT | 2453/7326 (33%) | 357/1074 (33%) |
| During DCT | 2444/7326 (33%) | 359/1074 (33%) | ||
| After DCT | 2430/7326 (33%) | 358/1074 (33%) | ||
| High bp | Before DCT | 168/1524 (11%) | 19/191 (10%) | |
| During DCT | 1356/1524 (89%) | 172/191 (90%) | ||
| After DCT | 0/1524 (0%) | 0/191 (0%) | ||
| Hyperlipidemia | Mention | Before DCT | 1459/4381 (33%) | 232/696 (33%) |
| During DCT | 1461/4381 (33%) | 232/696 (33%) | ||
| After DCT | 1461/4381 (33%) | 232/696 (33%) | ||
| High LDL | Before DCT | 79/114 (69%) | 25/28 (89%) | |
| During DCT | 35/114 (31%) | 3/28(11%) | ||
| After DCT | 0/114 (0%) | 0/28 (0%) | ||
| High chol. | Before DCT | 26/29 (90%) | 8/10 (80%) | |
| During DCT | 3/29 (10%) | 2/10 (20%) | ||
| After DCT | 0/29 (0%) | 0/10 (0%) | ||
| Diabetes | Mention | Before DCT | 2558/7699 (33%) | 346/1041 (33%) |
| During DCT | 2583/7699 (34%) | 348/1041 (33%) | ||
| After DCT | 2558/7699 (33%) | 347/1041 (33%) | ||
| A1C | Before DCT | 381/451 (84%) | 69/80 (86%) | |
| During DCT | 70/451 (16%) | 11/80 (14%) | ||
| After DCT | 0/451 (0%) | 0/80 (0%) | ||
| Glucose | Before DCT | 68/96 (71%) | 17/32 (53%) | |
| During DCT | 28/96 (29%) | 15/32 (47%) | ||
| After DCT | 0/96 (0%) | 0/32 (0%) | ||
| Obese | Mention | Before DCT | 569/1776 (32%) | 78/242 (32%) |
| During DCT | 641/1776 (36%) | 86/242 (36%) | ||
| After DCT | 566/1776 (32%) | 78/242 (32%) | ||
| BMI | Before DCT | 10/77 (13%) | 2/17 (12%) | |
| During DCT | 61/77 (79%) | 13/17 (76%) | ||
| After DCT | 6/77 (8%) | 2/17 (12%) | ||
| Medication | N/A | Before DCT | 12716/37646 (34%) | 1869/5534 (34%) |
| During DCT | 12559/37646 (33%) | 1832/5534 (33%) | ||
| After DCT | 12371/37646 (33%) | 1833/5534 (33%) |